Insight Molecular Diagnostics (IMDX) Debt to Equity (2015 - 2026)
Insight Molecular Diagnostics' (IMDX) quarterly Debt to Equity came in at -$0.01 in Q1 2026, down 135.1% year-on-year from $0.04 in Q1 2025, and down 9.33% quarter-over-quarter from -$0.01 in Q4 2025.
Insight Molecular Diagnostics (IMDX) Debt to Equity (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics has disclosed Debt to Equity across 12 years of filings, most recently posting -$0.01 for Q1 2026.
- Debt to Equity for Q1 2026 came in at -$0.01, down 135.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.01 (down 135.1% YoY), and the FY2025 annual result was -$0.01, up 26.77% from the prior year.
- Debt to Equity came in at -$0.01 for Q1 2026 at Insight Molecular Diagnostics, down from -$0.01 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.63 in Q2 2025 to a low of -$0.11 in Q3 2025.
- The 5-year median for Debt to Equity is $0.0 (2023), against an average of $0.05.
- Across the five-year window, Debt to Equity jumped 3456.76% in 2023 and tumbled 281.62% in 2025, its largest moves.
- Insight Molecular Diagnostics' Debt to Equity stood at $0.0 in 2022, then surged by 3456.76% to $0.11 in 2023, then plunged by 116.43% to -$0.02 in 2024, then increased by 26.77% to -$0.01 in 2025, then fell by 9.33% to -$0.01 in 2026.
- The last three Debt to Equity figures came in at -$0.01 (Q1 2026), -$0.01 (Q4 2025), and -$0.11 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 0.32 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 0.83 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 0.35 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 0.53 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -1.50 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 0.01 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 2.49 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 0.56 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -53.21 |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01 |
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | -0.11 |
| Jun 30, 2025 | 0.63 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | 0.06 |
| Dec 31, 2023 | 0.11 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.12 |
| Mar 31, 2021 | 0.03 |
| Dec 31, 2020 | 0.12 |